EOS Imaging has raised US$51 million in its IPO on NYSE Euronext
Venture-backed medical device company EOS Imaging has raised US$51 million in its IPO on NYSE Euronext. Based on the opening trade price, the company is valued at approximately US$146 million. Investors include medical device-focused venture capital firm NBGI Ventures and Edmond de Rothschild Investment Partners, which has been the lead investor and the company’s largest shareholder since 2005.
EOS Imaging designs, develops and markets EOS, a medical imaging system revolutionizing the treatment chain of the main osteoarticular diseases (hips, knees, back) and related orthopedic surgery. Based on the work of Physics Nobel Prize Winner Georges Charpak, the EOS system is the first imaging solution capable of producing, in one step, a 2D and 3D image of the upright skeleton with a very low radiation dose. EOS 2D/3D images are produced in the patient’s natural functional position, raising the accuracy of diagnosis, surgery and osteoarticular pathological follow-up.
The success of the IPO confirms EOS Imaging’s outstanding technology pedigree, its sound commercial and clinical proposition and its potential for strong commercial growth on a global level.
Oaklins’ team in France was appointed by the shareholders of EOS Imaging to launch an initial public offering and proposed listing of the company’s shares on compartment C of the regulated market of NYSE Euronext.
Talk to the deal team
Thibaut de Monclin
A group of Chilean investors has acquired Farmacias Ahumada
A group of Chilean investors has acquired Farmacias Ahumada S.A. from Walgreens Boots Alliance.Learn more
Alcidion has raised capital
Alcidion Group Ltd. (ASX:ALC) has raised capital via an institutional placement. The placement was well supported by existing shareholders whilst also welcoming several new institutional shareholders to the register. Proceeds from the raise will provide Alcidion with maximum flexibility and ensure a strong balance sheet to execute on its market opportunities and enable the firm to continue to drive revenue growth.Learn more
Bci has completed a capital increase
Banco de Crédito e Inversiones (Bci) has raised funds to support its local and international growth strategy and strengthen the company’s financial position to comply with the latest required regulatory capital ratios (Basel III).Learn more